Preventing driveline infection during left ventricular assist device support by the HeartMate 3: A survey-based study.
driveline infection
left ventricular assist device
primary prevention
Journal
Artificial organs
ISSN: 1525-1594
Titre abrégé: Artif Organs
Pays: United States
ID NLM: 7802778
Informations de publication
Date de publication:
Jul 2022
Jul 2022
Historique:
revised:
30
11
2021
received:
26
10
2021
accepted:
07
01
2022
pubmed:
28
1
2022
medline:
11
6
2022
entrez:
27
1
2022
Statut:
ppublish
Résumé
Driveline infection (DLI) is a significant source of morbidity and mortality during left ventricular assist device (LVAD) support yet limited studies are available to describe the center-level prevalence, preventive practices, and their potential effectiveness. We surveyed LVAD centers in the United States to determine program burden and preventive practices for DLI during HeartMate (HM) 3 support. An online, anonymous, question-based survey was sent to expert providers at implanting centers. Only a single respondent completed the survey for each center. As an exploratory analysis, we compared specific DLI preventive practices between centers with low (≤10%) and high (>10%) reported prevalence of DLI. Seventy-eight centers responded to the survey (response rate: 50%). Respondents were comprised of 37 (47%) heart failure cardiologists, 27 (35%) LVAD coordinators, and 14 (18%) cardiothoracic surgeons. The prevalence of DLI during HM3 was reported as ≤10% by 27 (35%), 11%-25% by 36 (46%), and >25% by 16 (19%) centers. Thirteen (17%) centers had a body mass index threshold for device placement, 29 (37%) utilized a counter incision, 66 (81%) placed an anchor stitch, and 69 (88%) used an external device to stabilize the DL. Proportionally, more centers with a low DLI prevalence used a wound vacuum 6 (22%) versus 3 (6%, p = 0.03) than those with high DLI. Variation exists in reported prevalence and practices of preventing and managing driveline infections across centers during HM3 support. Further studies are warranted to develop and assess the effectiveness of standardized preventive strategies.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1409-1414Subventions
Organisme : NIH HHS
ID : K23HL145140
Pays : United States
Organisme : National Institute of Health/National Heart, Lung, and Blood Institute
ID : K23HL145140
Organisme : National Center for Advancing Translational Science (NCATS) Clinical and Translational Science Award at Einstein-Montefiore
ID : UL1TR001073
Organisme : Abbott Inc.
Organisme : NIH HHS
ID : K23HL145140
Pays : United States
Informations de copyright
© 2022 International Center for Artificial Organs and Transplantation and Wiley Periodicals LLC.
Références
Molina EJ, Shah P, Kiernan MS, Cornwell WK III, Copeland H, Takeda K, et al. The Society of Thoracic Surgeons Intermacs 2020 annual report. Ann Thorac Surg. 2021;111:778-92.
Mehra MR, Uriel N, Naka Y, Cleveland JC Jr, Yuzefpolskaya M, Salerno CT, et al. A fully magnetically levitated left ventricular assist device. N Engl J Med. 2019;380:1618-27.
Shah P, Birk SE, Cooper LB, Psotka MA, Kirklin JK, Barnett SD, et al. Stroke and death risk in ventricular assist device patients varies by ISHLT infection category: an INTERMACS analysis. J Heart Lung Transplant. 2019;38:721-30.
Leuck A-M. Left ventricular assist device driveline infections: recent advances and future goals. J Thorac Dis. 2015;7:2151.
Wilcox JE, Cameron KA, Harap RS, Shanklin KL, Grady KL, Cohen ER, et al. Ventricular assist device driveline dressing change protocols: a need for standardization: a report from the SimVAD investigators. J Card Fail. 2019;25:695-7.
Maltais S, Kilic A, Nathan S, Keebler M, Emani S, Ransom J, et al. PREVENtion of HeartMate II pump thrombosis through clinical management: the PREVENT multi-center study. J Heart Lung Transplant. 2017;36:1-12.
Yarboro LT, Bergin JD, Kennedy JL, Ballew CC, Benton EM, Ailawadi G, et al. Technique for minimizing and treating driveline infections. Ann Cardiothorac Surg. 2014;3:557.
Cagliostro B, Levin AP, Fried J, Stewart S, Parkis G, Mody KP, et al. Continuous-flow left ventricular assist devices and usefulness of a standardized strategy to reduce drive-line infections. J Heart Lung Transplant. 2016;35:108-14.
Cirocchi R, Birindelli A, Biffl WL, Mutafchiyski V, Popivanov G, Chiara O, et al. What is the effectiveness of the negative pressure wound therapy (NPWT) in patients treated with open abdomen technique? A systematic review and meta-analysis. J Trauma Acute Care Surg. 2016;81:575-84.
Bernhardt AM, Schlöglhofer T, Lauenroth V, Mueller F, Mueller M, Schoede A, et al. Prevention and early treatment of driveline infections in ventricular assist device patients-the DESTINE staging proposal and the first standard of care protocol. J Crit Care. 2020;56:106-12.